SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-294698
Filing Date
2015-08-18
Accepted
2015-08-18 17:04:31
Documents
7
Period of Report
2015-08-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d21473d8k.htm 8-K 27004
2 EX-1.1 d21473dex11.htm EX-1.1 171289
3 EX-3.1 d21473dex31.htm EX-3.1 135940
4 EX-4.1 d21473dex41.htm EX-4.1 75294
5 EX-4.2 d21473dex42.htm EX-4.2 81875
6 EX-99.1 d21473dex991.htm EX-99.1 6334
7 EX-99.2 d21473dex992.htm EX-99.2 6561
  Complete submission text file 0001193125-15-294698.txt   505554
Mailing Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451
Business Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451 781-890-1199
BG Medicine, Inc. (Filer) CIK: 0001407038 (see all company filings)

IRS No.: 043506204 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33827 | Film No.: 151062034
SIC: 2835 In Vitro & In Vivo Diagnostic Substances